A. Branca

56.1k total citations
16 papers, 163 citations indexed

About

A. Branca is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, A. Branca has authored 16 papers receiving a total of 163 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in A. Branca's work include Chronic Myeloid Leukemia Treatments (6 papers), Eosinophilic Disorders and Syndromes (4 papers) and Particle physics theoretical and experimental studies (3 papers). A. Branca is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Eosinophilic Disorders and Syndromes (4 papers) and Particle physics theoretical and experimental studies (3 papers). A. Branca collaborates with scholars based in Italy, France and United States. A. Branca's co-authors include Giuseppe A. Palumbo, Daniele Tibullo, Cesarina Giallongo, Concetta Conticello, Annalisa Chiarenza, Francesco Di Raimondo, Fabio Stagno, Filíppo Gherlinzoni, Gregorio Barilà and Renato Zambello and has published in prestigious journals such as Physical Review Letters, Blood and Journal of Clinical Medicine.

In The Last Decade

A. Branca

15 papers receiving 162 citations

Peers

Countries citing papers authored by A. Branca

Since Specialization

Citations

This map shows the geographic impact of A. Branca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Branca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Branca more than expected).

Fields of papers citing papers by A. Branca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Branca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Branca. The network helps show where A. Branca may publish in the future.

Co-authorship network of co-authors of A. Branca

This figure shows the co-authorship network connecting the top 25 collaborators of A. Branca. A scholar is included among the top collaborators of A. Branca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Branca. A. Branca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Pharmacological Management of Transthyretin Amyloid Cardiomyopathy: Where We Are and Where We Are Going 2025 ·Journal of Clinical Medicine ·Laura De Michieli, Alessandro Lupi, Giulio Sinigiani, (unknown), Alessandro Salvalaggio, A. Branca, Stefano Da Pozzo, Stefania Rizzo, Diego Cecchin, Martina Perazzolo Marra, Tamara Berno, Domenico Corrado, Chiara Briani, Alberto Cipriani	1
2	Light-chain cardiac amyloidosis for the non-expert: pearls and pitfalls 2023 ·Internal and Emergency Medicine ·Laura De Michieli, Giulio Sinigiani, Monica De Gaspari, A. Branca, Stefania Rizzo, Cristina Basso, Livio Trentin, Sabino Iliceto, Martina Perazzolo Marra, Alberto Cipriani, Tamara Berno	2
3	P27 HIGH DOSE CYCLOPHOSPHAMIDE AS MOBILIZATION REGIMEN IN NEWLY DIAGNOSED MULTIPLE MYELOMA: SAFETY AND EFFICACY IN AN OUTPATIENT SETTING. SINGLE CENTER EXPERIENCE 2023 ·HemaSphere ·(unknown), A. Branca, Laura Pavan, (unknown), (unknown), (unknown), (unknown), (unknown), Francesco Piazza, (unknown), Federica Lessi, Carmela Gurrieri, Renato Zambello, Livio Trentin, Tamara Berno	0
4	A New Generation of Neutrino Cross Section Experiments: Challenges and Opportunities 2021 ·Symmetry ·A. Branca, G. Brunetti, A. Longhin, M. Martini, F. Pupilli, F. Terranova	6
5	Performance of the low threshold Optimum Trigger on CUORE data 2020 ·Journal of Physics Conference Series ·A. Branca	1
6	The CUORE Data Acquisition System 2019 ·Journal of Low Temperature Physics ·S. Copello, S. Di Domizio, A. Branca, A. Caminata, L. Canonica, A. Giachero, E. Guardincerri, L. Marini, M. Pallavicini, M. Vignati	1
7	Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma 2017 ·Clinical Radiology ·Carmelo Lacognata, Filippo Crimì, Annamaria Guolo, Cristiano Varin, (unknown), Stefania Vio, (unknown), Gregorio Barilà, (unknown), A. Branca, E. De Biasi, Filíppo Gherlinzoni, (unknown), (unknown), Tamara Berno, Renato Zambello	40
8	Search for an Ultralight Scalar Dark Matter Candidate with the AURIGA Detector 2017 ·Physical Review Letters ·A. Branca, M. Bonaldi, M. Cerdonio, L. Conti, P. Falferi, (unknown), R. Mezzena, A. Ortolan, G. A. Prodi, (unknown), G. Vedovato, Andrea Vinante, S. Vitale, J.-P. Zendri	38
9	Spontaneous splenic rupture following stem cell mobilization with G-CSF and plerixafor in AL amyloidosis 2015 ·Transfusion and Apheresis Science ·Federica Lessi, Piero Marson, Anna Colpo, (unknown), A. Branca, Tiziana Tison, Fausto Adami	4
10	Cytogenetic Impact on Lenalidomide Treatment in Relapsed/Refractory Multiple Myeloma: A Real-Life Evaluation 2015 ·Clinical Lymphoma Myeloma & Leukemia ·Renato Zambello, Laura Bonaldi, Tamara Berno, (unknown), (unknown), (unknown), A. Branca, (unknown), Claudia Minotto, Chiara Briani, Carmela Gurrieri, (unknown), (unknown), Francesco Piazza, (unknown), Livio Trentin, Gianpietro Semenzato	2
11	EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia 2013 ·Leukemia Research ·Mario Tiribelli, Massimiliano Bonifacio, Elisabetta Calistri, Gianni Binotto, Elena Maino, (unknown), (unknown), A. Branca, Filíppo Gherlinzoni, Gianpietro Semenzato, Rosaria Sancetta, Giovanni Pizzolo, Renato Fanin	7
12	EUTOS Score Predicts Optimal Response To Imatinib According To The Revised ELN Recommendations Better Than Sokal Score: A Study From The “Gruppo Triveneto LMC” 2013 ·Blood ·Mario Tiribelli, Massimiliano Bonifacio, Gianni Binotto, Elisabetta Calistri, Elena Maino, Roberta Zanotti, A. Branca, Marta Medeot, Gianpietro Semenzato, Giovanni Pizzolo, Renato Fanin	1
13	EUTOS Score Identifies Cases with Poor Outcome in Patients with Early Chronic Phase Chronic Myeloid Leukemia, Though Not Predictive for Optimal Response to Imatinib 2012 ·Blood ·Mario Tiribelli, Massimiliano Bonifacio, Elisabetta Calistri, Gianni Binotto, Elena Maino, (unknown), (unknown), A. Branca, Filíppo Gherlinzoni, Gianpietro Semenzato, Renato Bassan, Giovanni Pizzolo, Renato Fanin	6
14	Effects of second‐generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors 2011 ·Hematological Oncology ·Daniele Tibullo, Ignazio Barbagallo, Cesarina Giallongo, Piera La Cava, A. Branca, Concetta Conticello, Fabio Stagno, Annalisa Chiarenza, Giuseppe A. Palumbo, Francesco Di Raimondo	28
15	BRIT1/MCPH1 Expression in Chronic Myeloid Leukemia and Its Regulation of the G2/M Checkpoint 2011 ·Acta Haematologica ·Cesarina Giallongo, Daniele Tibullo, (unknown), A. Branca, Nunziatina Laura Parrinello, Paolo Spina, Fabio Stagno, Concetta Conticello, Annalisa Chiarenza, Paolo Vigneri, Giuseppe A. Palumbo, Francesco Di Raimondo	25
16	Mechanisms of Heme Oxygenase 1-Induced Resistance to Imatinib In CML Cells. 2010 ·Blood ·Daniele Tibullo, Ignazio Barbagallo, A. Branca, Cesarina Giallongo, Piera La Cava, Nunziatina Laura Parrinello, Giovanni Li Volti, A. Vanella, Fabio Stagno, Giuseppe A. Palumbo, Francesco Di Raimondo	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact